Table 2 HPV persistence and clearance rate at six-month follow up without treatment stratified by HPV type.
HPV genotypes | Frequency | Baseline | 6 months Persistent and clearance rate without treatment | |||
|---|---|---|---|---|---|---|
Persistent rate | Clearance rate | 95% CI | P-value | |||
High and probable high risk | 89 | 41 | 65.9%(27/41) | 34.1%(14/41) | 0.190–0.493 | < 0.001 |
Type-16 | 40 | 13 | 92.31%(12/13) | 7.69%(1/13) | -0.09-0.25 | 0.337 |
Type 16 alone | 24 | 8 | 87.5%(7/8) | 12.5%(1/8) | -0.17-0.42 | 0.351 |
Type-18 | 16 | 7 | 71.43%(5/7) | 28.57%(2/7) | -0.17-0.74 | 0.172 |
Type-35 | 12 | 6 | 50%(3/6) | 50%(3/6) | -0.08-1.08 | 0.076 |
Type-52 | 12 | 4 | 75%(3/4) | 25%(1/4) | -0.55-1.05 | 0.391 |
Type-58 | 18 | 8 | 75%(6/8) | 25%(2/8) | -0.14-0.64 | 0.170 |
Other high risks (HPV-31/33/39/45/51/56/59/66/68 | 24 | 15 | 60%(9/15) | 40%(6/15) | 0.12–0.68 | < 0.001 |
Possible and low risk | 31 | 21 | 71.4%(15/21) | 28.6%(6/21) | 0.08–0.49 | 0.01 |
Type-53 | 16 | 9 | 66.67%(6/9) | 33.33%(3/9) | -0.05-0.72 | 0.081 |
Type-70 | 8 | 6 | 66.67%(4/6) | 33.33%(2/6) | -0.02-0.88 | 0.175 |
Other possible and low risks (HPV-6/11/26/40/42/44/54/61/73/82) | 16 | 13 | 69.23%(9/13) | 30.77%(4/13) | 0.02–0.59 | 0.04 |
Single | 58 | 28 | 57.1%(16/28) | 42.9%(12/18) | 0.23–0.62 | < 0.001 |
Multiple | 31 | 13 | 84.6%(11/13) | 15.4%(2/13) | -0.07-0.38 | 0.165 |
